Results 11 to 20 of about 7,573 (248)
Neonatal Seizures and Purinergic Signalling [PDF]
Neonatal seizures are one of the most common comorbidities of neonatal encephalopathy, with seizures aggravating acute injury and clinical outcomes. Current treatment can control early life seizures; however, a high level of pharmacoresistance remains among infants, with increasing evidence suggesting current anti-seizure medication potentiating brain ...
Aida Menéndez-Méndez +2 more
exaly +6 more sources
Purinergic signalling in neuroregeneration
Purinergic signalling, adenosine 5′-triphosphate (ATP) as an extracellular signalling molecule, was proposed in 1972 (Burnstock, 1972). However, it was not generally accepted until the early 1990s when receptors for ATP and its breakdown product adenosine were cloned and characterised (Ralevic and Burnstock, 1998).
Geoffrey Burnstock
doaj +4 more sources
Purinergic signalling and diabetes [PDF]
The pancreas is an organ with a central role in nutrient breakdown, nutrient sensing and release of hormones regulating whole body nutrient homeostasis. In diabetes mellitus, the balance is broken-cells can be starving in the midst of plenty. There are indications that the incidence of diabetes type 1 and 2, and possibly pancreatogenic diabetes, is ...
Burnstock, G, Novak, I
openaire +5 more sources
Purinergic signalling in B cells
Adenosine and adenosine triphosphate are involved in purinergic signalling which plays important role in control of immune system. Much data have been obtained regarding impact of purinergic signalling on dendritic cells, macrophages, monocytes and T lymphocytes, however less attention has been paid to purinergic regulation of B cells.
Tomasz, Przybyła +2 more
openaire +4 more sources
Purinergic signalling: past, present and future
The discovery of non-adrenergic, non-cholinergic neurotransmission in the gut and bladder in the early 1960's is described as well as the identification of adenosine 5'-triphosphate (ATP) as a transmitter in these nerves in the early 1970's.
G. Burnstock
doaj +1 more source
Editorial: purinergic signalling-perspectives from Australia and New Zealand. [PDF]
Sluyter R, Cederholm JME, Vlajkovic SM.
europepmc +2 more sources
Purinergic Signalling in the Cochlea. [PDF]
The mammalian cochlea is the sensory organ of hearing with a delicate, highly organised structure that supports unique operating mechanisms. ATP release from the secretory tissues of the cochlear lateral wall (stria vascularis) triggers numerous physiological responses by activating P2 receptors in sensory, supporting and neural tissues.
Vlajkovic SM, Thorne PR.
europepmc +3 more sources
Purinergic Signalling: Pathophysiological Roles
In this review, after a summary of the history and current status of the receptors involved in purinergic signalling, we focus on the distribution and physiological roles of purines and pyrimidines in both short-term events such as neurotransmission, exocrine and endocrine secretion and regulation of immune cell function, and long-term events such as ...
M. Abbracchio, G. Burnstock
openaire +4 more sources
Purinergic Signaling in Neuroinflammation [PDF]
ATP is stored in millimolar concentrations within the intracellular medium but may be released to extracellular sites either through the damaged plasma membrane or by means of various transporters [...]
Dmitry Aminin, Peter Illes
openaire +3 more sources
Unmasking Adenosine: The Purinergic Signalling Molecule Critical to Arrhythmia Pathophysiology and Management [PDF]
Gareth DK Matthews, Andrew A Grace
doaj +2 more sources

